SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-006524
Filing Date
2021-02-03
Accepted
2021-02-03 17:20:27
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea134533-s3_oramedpharma.htm S-3 180332
2 OPINION OF SULLIVAN & WORCESTER LLP ea134533ex5-1_oramedpharma.htm EX-5.1 11353
3 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea134533ex23-1_oramedpharma.htm EX-23.1 3411
4 GRAPHIC img_001.jpg GRAPHIC 12780
5 GRAPHIC ex5-1_001.jpg GRAPHIC 17646
6 GRAPHIC ex5-1_002.jpg GRAPHIC 5947
7 GRAPHIC ex23-1_001.jpg GRAPHIC 6310
  Complete submission text file 0001213900-21-006524.txt   255629
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-252696 | Film No.: 21587304
SIC: 2834 Pharmaceutical Preparations